MNPR – monopar therapeutics inc. (US:NASDAQ)
Stock Stats
News
Monopar Therapeutics (NASDAQ:MNPR) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $104.00 price target on the stock.
Monopar Therapeutics (NASDAQ:MNPR) is now covered by analysts at Morgan Stanley. They set an "overweight" rating on the stock.
Monopar Therapeutics (NASDAQ:MNPR) was upgraded by analysts at Wall Stre
Is Monopar Therapeutics Inc. (NASDAQ:MNPR) Trading At A 46% Discount? [Yahoo! Finance]
Monopar Therapeutics (NASDAQ:MNPR) was downgraded by analysts at Raymond James Financial, Inc. from a "strong-buy" rating to an "outperform" rating.
Form 4 Monopar Therapeutics For: Dec 31 Filed by: Robinson Chandler
Form 4 Monopar Therapeutics For: Dec 31 Filed by: Cittadine Andrew
Form 4 Monopar Therapeutics For: Jan 01 Filed by: RIOUX PATRICE
Form 4 Monopar Therapeutics For: Dec 26 Filed by: Vu Quan Anh
Form 144 Monopar Therapeutics Filed by: KLAUSNER ARTHUR J
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.